期刊文献+

不停跳冠状动脉旁路移植术治疗非ST段抬高型心肌梗死效果分析

下载PDF
导出
摘要 心肌梗死是临床常见的急症之一,该病起病急、致死率高,甚至危及患者生命。非ST段抬高型心肌梗死(NSTEMI)为心肌梗死的类型之一,主要依靠静息心电图进行诊断与鉴别。目前,临床治疗该疾病的方式有选择性手术治疗、抗血小板治疗、抗缺血治疗等多种方法,而PCI是临床治疗NSTEMI的常用方式,但术后患者并发症较多,不利于预后[1]。有研究发现,不停跳冠状动脉旁路移植术(OPCABG)治疗该疾病可降低患者并发症发生率,更利于患者预后[2]。为进一步分析OPCABG治疗NSTEMI的临床效果,本研究回顾性分析2018年3月~2019年3月我院收治的60例NSTEMI患者临床资料,现报道如下。
作者 冀攀 董文通
出处 《中国现代医药杂志》 2020年第10期36-38,共3页 Modern Medicine Journal of China
  • 相关文献

参考文献8

二级参考文献74

  • 1李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:194
  • 2吴清玉,许建屏,高长青,万峰,孟强,吴若彬,肖明弟,肖锋,王东进,李洪银,李雷.冠状动脉旁路移植术技术指南[J].中华外科杂志,2006,44(22):1517-1524. 被引量:52
  • 3Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines(Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol,2002, 40(7) :1366-1374.
  • 4Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J,2002,23 ( 23 ) : 1809 -1840.
  • 5Erhardt L, Herlitz J, Bossaert L, et al. Task force on the management of chest pain. Eur Heart J, 2002, 23 ( 15 ) : 1153-1176.
  • 6CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet, 1996, 348(9038) :1329-1339.
  • 7Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med, 2001 , 345 ( 7 ) :494-502.
  • 8Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet, 2001, 358(9281):527-533.
  • 9Simoons ML, GUSTO IV-ACS Investigators. Effect of glycopmtein Ⅱb/Ⅲa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation:the GUSTO IV-ACS randomised trial. Lancet, 2001,357(9272) :1915-1924.
  • 10Platlat Receptor Inhibitor in Ischemic Syndrome Management(PRISM) study investigator. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Platelet Receptor Inhibition in Ischemic Syndrome Management ( PRISM )Study Investigators. N Engl J Med, 1998, 338(21 ) :1498-1505.

共引文献2185

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部